Cat Feline Hyperthyroid Radioiodine Treatment

Radioactive iodine (I-131) treatment offers a one-time cure for feline hyperthyroidism with minimal side effects, representing the gold standard welfare-positive treatment option for this common endocrine disease.

Key Facts

I-131 treatment requires a single injection, eliminating the need for daily medication
The treatment achieves cure rates of 95-98%, compared to ongoing management with methimazole
After treatment, cats require 2-4 weeks of isolation due to radiation safety requirements
Hypothyroidism after treatment occurs in approximately 5-10% of cats and requires thyroid supplementation
I-131 facilities must be licensed; availability varies by region but is expanding

Welfare Considerations

The welfare advantages of I-131 over lifelong methimazole are substantial. Daily pilling or transdermal gel application is stressful for many cats and requires consistent owner compliance. Methimazole side effects including facial scratching and bone marrow suppression require monitoring and dose adjustments. I-131 eliminates ongoing medication stress and monitoring requirements after the initial isolation period. The isolation period itself requires careful management to prevent boredom and maintain the cat's psychological welfare. For owners with financial access, I-131 represents the most welfare-positive treatment trajectory for hyperthyroid cats.

What You Can Do

Discuss I-131 treatment with a veterinary internist or specialist facility as the gold standard curative option
Prepare for the isolation period by providing enrichment, familiar bedding, and regular human contact within safety limits
Monitor kidney function carefully after I-131 treatment - unmasked CKD requires immediate management
Advocate for expanded I-131 treatment access and reduced costs to make this welfare-positive option more accessible